- Conditions
- Human Papillomavirus Vaccination
- Interventions
- Counseling
- Behavioral
- Lead sponsor
- Plan A Health, Inc
- Other
- Eligibility
- 18 Years to 35 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Louise, Mississippi
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–31
of 31
matching trials from the live ClinicalTrials.gov search.
- Conditions
- GARDASIL Vaccination
- Interventions
- Computer reminder system
- Behavioral
- Lead sponsor
- Planned Parenthood Federation of America
- Other
- Eligibility
- 19 Years to 26 Years · Female only
- Enrollment
- 365 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2012
- U.S. locations
- 9
- States / cities
- Glendale, Arizona • Arvada, Colorado • Denver, Colorado + 6 more
- Conditions
- Infections, Papillomavirus, Papillomavirus Vaccines
- Interventions
- GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM), Gardasil ® (Merck & Co. Inc), Placebo
- Biological
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 1,106 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2012
- U.S. locations
- 40
- States / cities
- Chandler, Arizona • San Diego, California • San Francisco, California + 36 more
- Conditions
- Meningococcal Meningitis
- Interventions
- Placebo + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine, MenACWY-CRM Conjugate Vaccine + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine
- Biological
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 11 Years to 18 Years
- Enrollment
- 801 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2012
- U.S. locations
- 17
- States / cities
- Birmingham, Alabama • Fremont, California • Madera, California + 14 more
- Conditions
- Recurrent Respiratory Papillomatosis (RRP)
- Interventions
- GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)
- Biological
- Lead sponsor
- Ohio State University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2035
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Vaccines, Meningococcal Vaccines
- Interventions
- rLP2086 and Gardasil, rLP2086, Gardasil
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 11 Years to 17 Years
- Enrollment
- 2,499 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2013
- U.S. locations
- 87
- States / cities
- Daphne, Alabama • Chandler, Arizona • Jonesboro, Arkansas + 57 more
- Conditions
- Human Papilloma Virus, Warts, Warts, Genital, Condyloma, Condylomata Acuminata
- Interventions
- nonavalent human papillomavirus vaccine
- Biological
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- San Francisco, California